Jaguar Animal Health, Inc. (NASDAQ:JAGX) is an animal health company that focuses on developing and commercializing leading gastrointestinal products for companion and production animals. Canalevia™ is Jaguar’s lead prescription drug product candidate for the treatment of various forms of diarrhea in dogs and is made from the Croton lechleri tree. The company’s other leading product, Neonorm™ Calf, is derived from the Croton lechleri tree and drug-free. Jaguar has nine active investigational new animal drug applications filed with the FDA. For more information, visit the company’s website at www.jaguaranimalhealth.com.